Towercrest Capital Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.8M | Buy |
7,356
+26
| +0.4% | +$6.06K | 0.28% | 41 |
|
|
2025
Q4 | $1.52M | Sell |
7,330
-23
| -0.3% | -$4.55K | 0.24% | 46 |
|
|
2025
Q3 | $1.36M | Buy |
7,353
+873
| +13% | +$150K | 0.22% | 48 |
|
|
2025
Q2 | $990K | Buy |
6,480
+17
| +0.3% | +$2.61K | 0.18% | 48 |
|
|
2025
Q1 | $1.07M | Sell |
6,463
-243
| -4% | -$38K | 0.2% | 46 |
|
|
2024
Q4 | $970K | Sell |
6,706
-15
| -0.2% | -$2.32K | 0.16% | 51 |
|
|
2024
Q3 | $1.09M | Sell |
6,721
-9
| -0.1% | -$1.43K | 0.18% | 51 |
|
|
2024
Q2 | $984K | Sell |
6,730
-8
| -0.1% | -$1.19K | 0.16% | 52 |
|
|
2024
Q1 | $1.07M | Buy |
6,738
+415
| +7% | +$66.1K | 0.18% | 50 |
|
|
2023
Q4 | $991K | Sell |
6,323
-307
| -5% | -$47.1K | 0.18% | 49 |
|
|
2023
Q3 | $1.03M | Sell |
6,630
-48
| -0.7% | -$7.92K | 0.2% | 49 |
|
|
2023
Q2 | $1.11M | Buy |
6,678
+181
| +3% | +$29.2K | 0.21% | 50 |
|
|
2023
Q1 | $1.01M | Buy |
6,497
+141
| +2% | +$22.8K | 0.21% | 49 |
|
|
2022
Q4 | $1.12M | Buy |
6,356
+309
| +5% | +$53.4K | 0.25% | 47 |
|
|
2022
Q3 | $988K | Buy |
6,047
+1
| +0% | +$169 | 0.23% | 46 |
|
|
2022
Q2 | $1.07M | Hold |
6,046
| – | – | 0.24% | 46 |
|
|
2022
Q1 | $1.07M | Sell |
6,046
-57
| -0.9% | -$9.7K | 0.21% | 49 |
|
|
2021
Q4 | $1.04M | Sell |
6,103
-70
| -1% | -$11.5K | 0.19% | 48 |
|
|
2021
Q3 | $997K | Sell |
6,173
-34
| -0.5% | -$5.8K | 0.19% | 49 |
|
|
2021
Q2 | $1.02M | Sell |
6,207
-15
| -0.2% | -$2.48K | 0.2% | 45 |
|
|
2021
Q1 | $1.02M | Sell |
6,222
-146
| -2% | -$23.6K | 0.22% | 43 |
|
|
2020
Q4 | $1M | Buy |
6,368
+1,221
| +24% | +$180K | 0.23% | 46 |
|
|
2020
Q3 | $766K | Buy |
5,147
+66
| +1% | +$9.77K | 0.19% | 46 |
|
|
2020
Q2 | $715K | Buy |
5,081
+1
| +0% | +$146 | 0.19% | 47 |
|
|
2020
Q1 | $666K | Sell |
5,080
-445
| -8% | -$63.1K | 0.2% | 51 |
|
|
2019
Q4 | $806K | Sell |
5,525
-12
| -0.2% | -$1.63K | 0.21% | 48 |
|
|
2019
Q3 | $716K | Sell |
5,537
-162
| -3% | -$21.3K | 0.2% | 48 |
|
|
2019
Q2 | $793K | Buy |
5,699
+204
| +4% | +$28.2K | 0.22% | 47 |
|
|
2019
Q1 | $768K | Buy |
5,495
+169
| +3% | +$22.6K | 0.22% | 45 |
|
|
2018
Q4 | $687K | Buy |
5,326
+12
| +0.2% | +$1.67K | 0.22% | 45 |
|
|
2018
Q3 | $734K | Buy |
5,314
+111
| +2% | +$14.8K | 0.22% | 48 |
|
|
2018
Q2 | $631K | Buy |
+5,203
| New | +$649K | 0.2% | 56 |
|
Other funds holding JNJ
VCM
VPM
Towercrest Capital Management's JNJ Position: Q1 2026 in Review
Towercrest Capital Management increased its Johnson & Johnson (JNJ) stake by 0.35% in Q1 2026, buying an estimated $6.06K and bringing the position to 7,356 shares worth $1.8M. The position accounts for 0.28% of the portfolio, ranked #41.
Towercrest Capital Management first reported a position in JNJ in Q2 2018 and has held it in 32 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Towercrest Capital Management held 7,356 shares of Johnson & Johnson worth $1.8M as of Q1 2026.
- Towercrest Capital Management bought 26 Johnson & Johnson shares in Q1 2026, an estimated $6.06K.
- Johnson & Johnson made up 0.28% of Towercrest Capital Management's portfolio in Q1 2026, its #41 holding.
- Towercrest Capital Management first reported a position in Johnson & Johnson in Q2 2018 and has held it in 32 quarters since.
- 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Towercrest Capital Management's 13F filing for Q1 2026, filed 1 May 2026.